Probably by 2024, every Indian will get vaccinated SII
NEW DELHI: Serum Institute of India (SII) CEO Adar Poonawalla has said that every Indian will get vaccinated for Covid 19 probably by 2024. Speaking...
Summer of 2021 will be almost normal Bill Gates
NEW YORK: Microsoft co-founder Bill Gates believes that a "lot of things" will be back to "normal" by the summer of 2021 if Covid-19...
Social distancing most effective tool to combat COVID-19 Study
NEW YORK: Physical distancing is an effective intervention in all settings, versus other forms of transmission rate depending on the transmission probability, according to...
Delhi reports 7,546 new COVID-19 cases, 98 deaths
NEW DELHI: A total of 7,546 new COVID-19 cases were reported in Delhi on Thursday taking the total count to 5,10,630. According to the Delhi...
Rs 2,000 fine for not wearing a mask in Delhi Kejriwal
NEW DELHI: Delhi Chief Minister Arvind Kejriwal announced that the fine for not wearing a mask has been increased to Rs 2,000 in the...
Hoping to get 1000 volunteers for Covaxin trial, says PGIMS V-C
ROHTAK: Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, hopes to get 1,000 healthy volunteers by Thursday for the third-phase...
China ready to cooperate with India, other BRICS countries on COVID-19 vaccine development Xi Jinping
BEIJING: China is prepared to cooperate with India and other BRICS nations in the development of vaccines against COVID-19, said Chinese President Xi Jinping...
Air quality improves in Delhi, parts of city record 'moderate' AQI
NEW DELHI: Air pollution levels in the national capital significantly improved on Tuesday with several parts of the city reporting Air Quality Index (AQI)...
Delhi to have colder days, temperature to fall by 3-4 degrees
NEW DELHI: The temperature in the national capital would start falling from Monday under the impact of the western disturbances, the India Meteorological Department said,...
Vaccinating 130Cr people with injectable Covaxin a challenge Bharat Biotech
HYDERABAD: Even as India's first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech on Monday raised the logistical...